title: Frequency of RET mutations in long- and short-segment Hirschsprung disease.
abstract: Hirschsprung disease, or congenital aganglionic megacolon, is a genetic disorder of neural crest development affecting 1:5,000 newborns. Mutations in the RET proto-oncogene, repeatedly identified in the heterozygous state in both long- and short-segment Hirschsprung patients, lead to loss of both transforming and differentiating capacities of the activated RET through a dominant negative effect when expressed in appropriate cellular systems. The approach of single-strand conformational polymorphism analysis established for all the 20 exons of the RET proto-oncogene, and previously used to screen for point mutations in Hirschsprung patients allowed us to identify seven additional mutations among 39 sporadic and familial cases of Hirschsprung disease (detection rate 18%). This relatively low efficiency in detecting mutations of RET in Hirschsprung patients cannot be accounted by the hypothesis of genetic heterogeneity, which is not supported by the results of linkage analysis in the pedigrees analyzed so far. Almost 74% of the point mutations in our series, as well as in other patient series, were identified among long segment patients, who represented only 25% of our patient population. The finding of a C620R substitution in a patient affected with total colonic aganglionosis confirms the involvement of this mutation in the pathogenesis of different phenotypes (i.e., medullary thyroid carcinoma and Hirschsprung). Finally the R313Q mutation identified for the first time in homozygosity in a child born of consanguineous parents is associated with the most severe Hirschsprung phenotype (total colonic aganglionosis with small bowel involvement).
authors.affiliation: Laboratorio Genetica Molecolare, Istituto G. Gaslini, Genova, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Seri
authors.forename: L
authors.initials: L
authors.lastname: Yin
authors.forename: V
authors.initials: V
authors.lastname: Barone
authors.forename: A
authors.initials: A
authors.lastname: Bolino
authors.forename: I
authors.initials: I
authors.lastname: Celli
authors.forename: R
authors.initials: R
authors.lastname: Bocciardi
authors.forename: B
authors.initials: B
authors.lastname: Pasini
authors.forename: I
authors.initials: I
authors.lastname: Ceccherini
authors.forename: M
authors.initials: M
authors.lastname: Lerone
authors.forename: U
authors.initials: U
authors.lastname: Kristoffersson
authors.forename: L T
authors.initials: LT
authors.lastname: Larsson
authors.forename: J M
authors.initials: JM
authors.lastname: Casasa
authors.forename: D T
authors.initials: DT
authors.lastname: Cass
authors.forename: M J
authors.initials: MJ
authors.lastname: Abramowicz
authors.forename: J M
authors.initials: JM
authors.lastname: Vanderwinden
authors.forename: I
authors.initials: I
authors.lastname: Kravcenkiene
authors.forename: I
authors.initials: I
authors.lastname: Baric
authors.forename: M
authors.initials: M
authors.lastname: Silengo
authors.forename: G
authors.initials: G
authors.lastname: Martucciello
authors.forename: G
authors.initials: G
authors.lastname: Romeo
mesh_terms: D004252:DNA Mutational Analysis; D029721:Drosophila Proteins; D005091:Exons; D006627:Hirschsprung Disease / Q000235:genetics*; D006801:Humans; D009154:Mutation; D017354:Point Mutation; D018807:Polymorphism, Single-Stranded Conformational; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D051096:Proto-Oncogene Proteins c-ret; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics*; D017384:Sequence Deletion
chemical_list: D029721:Drosophila Proteins; C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D051096:Proto-Oncogene Proteins c-ret; D020794:Receptor Protein-Tyrosine Kinases; C416649:Ret protein, Drosophila